New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma

Share Article

Italian researchers say a mesothelioma patient’s response to a treatment for excess lung fluid can also help determine prognosis.

Mesothelioma Prognosis after Talc Therapy

Talc Therapy Response and Mesothelioma Prognosis

Persistent lung expansion after pleural talc poudrage... is demonstrated to be a stronger factor in predicting survival.

Doctors in Novara, Italy have found that talc pleurodesis response can be a better predictor of outcomes for people with mesothelioma than other clinical factors. Click here to read details of the new study on the Surviving Mesothelioma website.

Thoracic surgeons and pathologists at the University of Eastern Piedmont followed the cases of 172 mesothelioma patients who underwent talc pleurodesis treatment for excess lung fluid.

“Persistent lung expansion after pleural talc poudrage and absence of fluid recurrence is demonstrated to be a stronger factor in predicting survival than clinical stage and other clinical variables,” writes thoracic surgeon Dr. Ottavio Rena.

The study, published in the Annals of Thoracic Surgery, also found that mesothelioma patients with the poorest prognosis tended to have later stage disease, non-epithelioid mesothelioma, and/or be in poorer overall health.

“Talc pleurodesis is a common treatment for one of the most common and difficult symptoms of mesothelioma and this study gives some valuable insight into its implications,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.

For a more complete explanation of talc pleurodesis and details of the new study, see Response to Talc Treatment May Predict Mesothelioma Prognosis, now available on the Surviving Mesothelioma website.

Rena, O et al, “Persistent Lung Expansion After Pleural Talc Poudrage in Non-Surgically Resected Malignant Pleural Mesothelioma”, February 7, 2015, Annals of Thoracic Surgery, Epub ahead of print, http://icvts.oxfordjournals.org/content/17/suppl_1/S1.94

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website